Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page
- ChecktodayChange DetectedDeleted entries in the Study Documents section that provided access to major trial documents (Statistical Analysis Plan, Study Protocol) and the data-sharing/IPD information, reducing availability of key methodological and transparency resources for the DREAMM-3 trial.SummaryDifference16%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4. This indicates a minor update/patch to the page’s metadata.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now lists 136 investigational sites across various countries and updates trial durations/outcome timeframes (e.g., weeks-based horizons), reflecting the current scope of the DREAMM-3 study.SummaryDifference4%

- Check36 days agoChange DetectedThe page's related topics were expanded to include Multiple myeloma and MedlinePlus Genetics, and the site revision was updated from v3.6.0 to v3.6.3.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page now indicates the study is no longer recruiting participants, clarifying current enrollment status. Additionally, new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added and the Intervention/Treatment label was reformatted.SummaryDifference0.3%

- Check57 days agoChange DetectedA new page revision tag Revision: v3.5.5 was added, and the previous Revision: v3.5.4 was removed, indicating an update to the page's versioning.SummaryDifference0.0%

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.